Navigation Links
Webcast Alert: Transgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast
Date:10/22/2008

OMAHA, Neb., Oct. 22 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

What: Transgenomic Inc. Third Quarter 2008 Earnings Release

Conference Call

When: Wednesday, October 29, 2008 @ 5:00 p.m. Eastern

Where: http://www.transgenomic.com/events.asp?id=6

How: Live over the Internet -- Simply log on to the web at the

address above.

Contact: Investor Relations, 402-452-5400

To access the call via telephone, call 800-862-9098 or 785-424-1051. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, November 12, 2008. To access, dial 888-566-0849 or 402-220-0428.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: http://www.transgenomic.com.


'/>"/>
SOURCE Transgenomic Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amgen Announces Webcast of 2008 Third Quarter Financial Results
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
6. Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
8. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
9. Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
11. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How to read brain activity? 2California Cancer Specialists Medical Group Inc Opens Outpatient Cancer Center in South Pasadena Calif With Renowned Medical Staff State of the 53860 1California Cancer Specialists Medical Group Inc Opens Outpatient Cancer Center in South Pasadena Calif With Renowned Medical Staff State of the 53860 2US Oncology Reports Second Quarter Operating Results 53858 1US Oncology Reports Second Quarter Operating Results 53858 2US Oncology Reports Second Quarter Operating Results 53858 3US Oncology Reports Second Quarter Operating Results 53858 4US Oncology Reports Second Quarter Operating Results 53858 5US Oncology Reports Second Quarter Operating Results 53858 6US Oncology Reports Second Quarter Operating Results 53858 7US Oncology Reports Second Quarter Operating Results 53858 8US Oncology Reports Second Quarter Operating Results 53858 9US Oncology Reports Second Quarter Operating Results 53858 10US Oncology Reports Second Quarter Operating Results 53858 11US Oncology Reports Second Quarter Operating Results 53858 12US Oncology Reports Second Quarter Operating Results 53858 13US Oncology Reports Second Quarter Operating Results 53858 14US Oncology Reports Second Quarter Operating Results 53858 15US Oncology Reports Second Quarter Operating Results 53858 16US Oncology Reports Second Quarter Operating Results 53858 17US Oncology Reports Second Quarter Operating Results 53858 18US Oncology Reports Second Quarter Operating Results 53858 19US Oncology Reports Second Quarter Operating Results 53858 20US Oncology Reports Second Quarter Operating Results 53858 21US Oncology Reports Second Quarter Operating Results 53858 22US Oncology Reports Second Quarter Operating Results 53858 23US Oncology Reports Second Quarter Operating Results 53858 24US Oncology Reports Second Quarter Operating Results 53858 25PharmatrophiX Initially Funded by the Alzheimers Drug Discovery Foundation Announces Exclusive Global Collaboration with Elan 13417 1PharmatrophiX Initially Funded by the Alzheimers Drug Discovery Foundation Announces Exclusive Global Collaboration with Elan 13417 2PharmatrophiX Initially Funded by the Alzheimers Drug Discovery Foundation Announces Exclusive Global Collaboration with Elan 13417 3